Medicare Enrolled
Dr. Mumtaz Almansour, M.D.
Family Medicine · El Cajon, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Almansour from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Almansour?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Almansour
Dr. Mumtaz Almansour is a family medicine specialist in El Cajon, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Almansour performed 11,355 Medicare services across 2,283 unique beneficiaries.
Between the years covered by Open Payments, Dr. Almansour received a total of $19,489 from 54 pharmaceutical and/or device companies across 685 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Almansour is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in CA
$19,489 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,355
Medicare services
Top 1% in CA for family medicine
2,283
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~631 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
2,912 | $50 | $80 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
2,384 | $41 | $61 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
1,483 | $39 | $58 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,477 | $46 | $80 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
1,132 | $32 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
978 | $61 | $80 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
287 | $4 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
286 | $101 | $135 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
99 | $8 | $10 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
91 | $138 | $150 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
72 | $72 | $85 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
71 | $33 | $35 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
32 | $16 | $50 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
23 | $16 | $45 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
15 | $56 | $85 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
13 | $238 | $335 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$19,489
Total received (2018-2024)
Avg $2,784/year across 7 years
Top 1% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
685
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,967 (66.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,571 (23.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,951 (10.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,695
2023
$6,105
2022
$4,781
2021
$2,198
2020
$1,156
2019
$2,233
2018
$1,322
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$255
AstraZeneca Pharmaceuticals LP
$213
PFIZER INC.
$212
Sumitomo Pharma America, Inc.
$184
Amgen Inc.
$160
ABBVIE INC.
$124
Esperion Therapeutics, Inc.
$87
Otsuka America Pharmaceutical, Inc.
$72
GlaxoSmithKline, LLC.
$57
GENZYME CORPORATION
$49
IRONWOOD PHARMACEUTICALS, INC
$40
Abbott Laboratories
$34
Merck Sharp & Dohme LLC
$31
Dexcom, Inc.
$29
Novartis Pharmaceuticals Corporation
$27
Boston Scientific Corporation
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
ViiV Healthcare Company
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Philips North America LLC
$16
Top 3 companies account for 40.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$7,450
Biohaven Pharmaceutical Holding Company Ltd.
$1,951
Lilly USA, LLC
$1,121
Novartis Pharmaceuticals Corporation
$715
Boehringer Ingelheim Pharmaceuticals, Inc.
$642
AstraZeneca Pharmaceuticals LP
$584
Sunovion Pharmaceuticals Inc.
$464
GlaxoSmithKline, LLC.
$459
PFIZER INC.
$433
Abbott Laboratories
$417
Esperion Therapeutics, Inc.
$407
ABBVIE INC.
$354
Bayer HealthCare Pharmaceuticals Inc.
$349
SANOFI-AVENTIS U.S. LLC
$347
Sumitomo Pharma America, Inc.
$327
Mannkind Corporation
$322
Dexcom, Inc.
$317
AbbVie Inc.
$286
Astellas Pharma US Inc
$256
Amarin Pharma Inc.
$212
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$204
Janssen Pharmaceuticals, Inc
$178
Corium, LLC
$157
MannKind Corporation
$155
Merck Sharp & Dohme Corporation
$154
Bayer Healthcare Pharmaceuticals Inc.
$115
Otsuka America Pharmaceutical, Inc.
$113
Xeris Pharmaceuticals, Inc.
$104
Ironwood Pharmaceuticals, Inc
$79
DEXCOM, INC.
$73
Lundbeck LLC
$60
Takeda Pharmaceuticals U.S.A., Inc.
$57
Vision Quest Industries Inc.
$50
GENZYME CORPORATION
$49
IRONWOOD PHARMACEUTICALS, INC
$40
Teva Pharmaceuticals USA, Inc.
$40
Regeneron Healthcare Solutions, Inc.
$38
E.R. Squibb & Sons, L.L.C.
$38
Biohaven Pharmaceuticals, Inc.
$37
Almatica Pharma LLC
$35
SANOFI PASTEUR INC.
$32
Merck Sharp & Dohme LLC
$31
Scilex Pharmaceuticals Inc.
$29
Boston Scientific Corporation
$25
Insulet Corporation
$22
Gilead Sciences, Inc.
$22
Novo Nordisk Inc
$21
ViiV Healthcare Company
$20
TherapeuticsMD, Inc.
$20
Valeritas, Inc.
$20
Philips North America LLC
$16
Cranial Technologies, Inc
$16
Avion Pharmaceuticals
$14
Allergan, Inc.
$14
Top 3 companies account for 54.0% of all-time payments
Associated products mentioned in payments ›
(CK7) Extended Holter · ADLARITY · AFREZZA · AIRSUPRA · AJOVY · ANNOVERA · APRETUDE · APTIOM · Adlarity · Aimovig · Assurity Pacemaker · BAQSIMI · BASAGLAR · BELSOMRA · BREATHTEK · BREZTRI · CHANTIX · CONFIRM RX · CREON · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DUPIXENT · Dexcom G6 Transmitter · Doc Band · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GARDASIL · GEMTESA · GLYXAMBI · GRALISE · GVOKE HYPOPEN · GVOKE PFS · Gloperba · JANUVIA · JARDIANCE · KYNMOBI · Kerendia · LEQVIO · LYUMJEV · Linzess · MOUNJARO · MYRBETRIQ · NAVITOR · NEXLETOL · NEXLIZET · NURTEC ODT · OFEV · Omnipod · Otezla · PAXLOVID · PRADAXA · PRALUENT · Prolia · QULIPTA · REXULTI · Repatha · SOLIQUA 100/33 · STEGLUJAN · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TEZSPIRE · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Truvada · UBRELVY · Uloric · V-GO · VAXELIS · VIBERZI · VYEPTI · Vascepa · XARELTO · XIFAXAN · XIFAXANIBSD · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
1,288
Per 100K population
39.2
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Almansour is a clinical cardiology specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 1% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Almansour experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Almansour performed 2,912 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Almansour receive payments from pharmaceutical companies?
Yes. Dr. Almansour received a total of $19,489 from 54 companies across 685 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Almansour's costs compare to other family medicine physicians in El Cajon?
Dr. Almansour's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Almansour) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in El Cajon
Browse family medicine physicians in El Cajon ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Biohaven Pharmaceutical Holding Company Ltd. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceutical Holding Company Ltd.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology